FilingIndex
DEF 14AThe Ballot

CRESCENT BIOPHARMA, INC. files DEF 14A

Filed Apr 20, 2017 · 9y ago · Accession 0001558370-17-002742

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
CBIO
CIK
1253689
Form type
DEF 14A
Filing date
Apr 20, 2017
Report date
May 25, 2017
Document
glyc-20170525xdef14a.htm
Size
1.1 MB